QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has filed a complaint against bioMérieux S.A.

Nicholas Enrich, acting assistant administrator for global health at U.S.A.I.D., spelled out projections for human health ...

QIAGEN has filed a lawsuit against bioMérieux in the German Unified Patent Court to protect its QuantiFERON technology, specifically its Europea ...

Trump administration cuts to USAID drastically impact global health, including Taiwan's epidemic monitoring and access to WHO ...

A study of bacteria from patients at a sexual health clinic found increasing resistance to tetracyclines in Neisseria ...